Dermatofibroma screening: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for Dermatofibroma. | There is insufficient evidence to recommend routine [[screening]] for Dermatofibroma. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine screening for Dermatofibroma | There is insufficient evidence to recommend routine [[screening]] for Dermatofibroma | ||
==References== | ==References== | ||
| Line 15: | Line 15: | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Primary care]] | [[Category:Primary care]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
Revision as of 18:44, 27 June 2019
|
Dermatofibroma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Dermatofibroma screening On the Web |
|
American Roentgen Ray Society Images of Dermatofibroma screening |
|
Risk calculators and risk factors for Dermatofibroma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There is insufficient evidence to recommend routine screening for Dermatofibroma.
Screening
There is insufficient evidence to recommend routine screening for Dermatofibroma